Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications

The abundance of scientific evidence has shown that many synthetic drugs can cause serious adverse effects in patients. Recently, the search of natural therapeutic agents with low adverse effects has attracted much attention. In particular, considerable interest has focused on edible and medicinal plants, which play an important role in human diet, and have been used for disease treatment since ancient times. Crataegus monogyna Jacq. (hawthorn) is one of the most important edible plants of the Rosaceae family and is also used in traditional medicine. Growing evidence has shown that this plant has various interesting physiological and pharmacological activities due to the presence of different bioactive natural compounds. In addition, scientific evidence suggests that the toxicity of hawthorn is negligible. Therefore, the aim of this paper is to provide a critical review of the available scientific literature about pharmacological activities as well as botanical aspects, phytochemistry and clinical impacts of C. monogyna.

[1]  S. Nabavi,et al.  Role of quercetin as an alternative for obesity treatment: you are what you eat! , 2015, Food chemistry.

[2]  M. Izadi,et al.  Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. , 2015, Food chemistry.

[3]  E. Şener,et al.  Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model , 2015, Pharmaceutical biology.

[4]  S. Nabavi,et al.  Modulation of human miR-17-3p expression by methyl 3-O-methyl gallate as explanation of its in vivo protective activities. , 2014, Molecular nutrition & food research.

[5]  Solomon Habtemariam,et al.  The antidiabetic therapeutic potential of dietary polyphenols. , 2014, Current pharmaceutical biotechnology.

[6]  M. Amri,et al.  Comparative analysis of Tunisian wild Crataegus azarolus (yellow azarole) and Crataegus monogyna (red azarole) leaf, fruit, and traditionally derived syrup: phenolic profiles and antioxidant and antimicrobial activities of the aqueous-acetone extracts. , 2013, Journal of agricultural and food chemistry.

[7]  Arman Zahra,et al.  Attenuation of Cyclosporine-Induced Sperm Impairment and Embryotoxicity by Crataegus monogyna Fruit Aqueous Extract , 2013, Cell journal.

[8]  W. Setzer,et al.  Antioxidant and antihemolytic activity of lipid-soluble bioactive substances in avocado fruits , 2013 .

[9]  Ana Maria Carvalho,et al.  Development of hydrosoluble gels with Crataegus monogyna extracts for topical application: Evaluation of antioxidant activity of the final formulations , 2013 .

[10]  S. Hasanzadeh,et al.  Crataegus monogyna fruit aqueous extract as a protective agent against doxorubicin-induced reproductive toxicity in male rats , 2013, Avicenna journal of phytomedicine.

[11]  E. Attard,et al.  Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico models , 2013 .

[12]  M. Simirgiotis Antioxidant Capacity and HPLC-DAD-MS Profiling of Chilean Peumo (Cryptocarya alba) Fruits and Comparison with German Peumo (Crataegus monogyna) from Southern Chile , 2013, Molecules.

[13]  A. Marseglia,et al.  A simple GC-MS method for the screening of betulinic, corosolic, maslinic, oleanolic and ursolic acid contents in commercial botanicals used as food supplement ingredients. , 2013, Food chemistry.

[14]  S. Nabavi,et al.  Biological Activities of Freshwater Algae, Spirogyra singularis Nordstedt , 2013 .

[15]  Ana Maria Carvalho,et al.  Crataegus monogyna buds and fruits phenolic extracts: Growth inhibitory activity on human tumor cell lines and chemical characterization by HPLC–DAD–ESI/MS , 2012 .

[16]  A. Sureda,et al.  Protective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxidative stress in rat’s kidney , 2012, Molecular and Cellular Biochemistry.

[17]  T. Dickinson,et al.  A review of the chemistry of the genus Crataegus. , 2012, Phytochemistry.

[18]  S. Nabavi,et al.  In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue , 2012 .

[19]  Ana Maria Carvalho,et al.  Characterization of phenolic compounds in flowers of wild medicinal plants from Northeastern Portugal. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  S. Nabavi,et al.  Protective effects of Allium paradoxum against gentamicin-induced nephrotoxicity in mice. , 2012, Food & function.

[21]  S. Hasanzadeh,et al.  Crataegus monogyna aqueous extract ameliorates cyclophosphamide-induced toxicity in rat testis: stereological evidences. , 2012, Acta medica Iranica.

[22]  K. Cheng,et al.  Decrease of Blood Lipids Induced by Shan-Zha (Fruit of Crataegus pinnatifida) is Mainly Related to an Increase of PPARα in Liver of Mice Fed High-Fat Diet , 2011, Hormone and Metabolic Research.

[23]  M. Azadbakht,et al.  Protective effect of hawthorn extract against genotoxicity induced by methyl methanesulfonate in human lymphocytes , 2011, Toxicology and industrial health.

[24]  Ana Maria Carvalho,et al.  Comparing the composition and bioactivity of Crataegus Monogyna flowers and fruits used in folk medicine. , 2011, Phytochemical analysis : PCA.

[25]  S. Habtemariam α-Glucosidase Inhibitory Activity of Kaempferol-3-O-rutinoside , 2011, Natural product communications.

[26]  S. N. Devaraj,et al.  Immunomodulatory effect of Hawthorn extract in an experimental stroke model , 2010, Journal of Neuroinflammation.

[27]  N. Öztürk,et al.  Effects of hawthorn seed and pulp extracts on the central nervous system , 2010, Pharmaceutical biology.

[28]  Myeon-Hyeon Wang,et al.  Comparison of Crataegus pinnatifida Bunge var. typica Schneider and C. pinnatifida Bunge fruits for antioxidant, anti-α-glucosidase, and anti-inflammatory activities , 2010 .

[29]  S. Dahmer,et al.  Health effects of hawthorn. , 2010, American family physician.

[30]  S. N. Devaraj,et al.  Hawthorn extract reduces infarct volume and improves neurological score by reducing oxidative stress in rat brain following middle cerebral artery occlusion , 2009, International Journal of Developmental Neuroscience.

[31]  B. Gillespie,et al.  Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial , 2009, European journal of heart failure.

[32]  J. Hilbert,et al.  Phenolic profiles and antioxidative effects of hawthorn cell suspensions, fresh fruits, and medicinal dried parts , 2009 .

[33]  S. Akhlaghpoor,et al.  Radioprotective effects of hawthorn against genotoxicity induced by gamma irradiation in human blood lymphocytes , 2009, Radiation and environmental biophysics.

[34]  M. Korkmaz Medicinal Plant Diversity of Western Mediterrenean Region in Turkey , 2009 .

[35]  Wilhelm Gaus,et al.  The efficacy and safety of Crataegus extract WS® 1442 in patients with heart failure: The SPICE trial , 2008, European journal of heart failure.

[36]  N. Menković,et al.  Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. , 2008, Journal of agricultural and food chemistry.

[37]  E. Ernst,et al.  Hawthorn extract for treating chronic heart failure. , 2008, The Cochrane database of systematic reviews.

[38]  S. Hosseinimehr,et al.  Protective effect of hawthorn extract against genotoxicity induced by cyclophosphamide in mouse bone marrow cells. , 2008, Environmental toxicology and pharmacology.

[39]  T. Filtz,et al.  Hawthorn (Crataegus monogyna Jacq.) extract exhibits atropine-sensitive activity in a cultured cardiomyocyte assay , 2008, Journal of Natural Medicines.

[40]  A. Wojdyło,et al.  Antioxidant activity of the phenolic compounds of hawthorn, pine and skullcap , 2007 .

[41]  G. Piluzza,et al.  Plant resources used for traditional ethnoveterinary phytotherapy in Sardinia (Italy) , 2007, Genetic Resources and Crop Evolution.

[42]  T. Filtz,et al.  Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[43]  E. Attard,et al.  The Potential Angiotensin-Converting Enzyme Inhibitory Activity of Oleanolic Acid in the Hydroethanolic Extract of Crataegus monogyna Jacq , 2006 .

[44]  A. Maruška,et al.  Capillary electrophoretic analysis of flavonoids in single-styled hawthorn (Crataegus monogyna Jacq.) ethanolic extracts. , 2006, Journal of chromatography. A.

[45]  E. Ernst,et al.  Adverse-Event Profile of Crataegus Spp. , 2006, Drug safety.

[46]  T. Marakoğlu,et al.  Hawthorn (Crataegus spp.) fruit : some physical and chemical properties , 2005 .

[47]  T. Tseng,et al.  Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. , 2005, Journal of agricultural and food chemistry.

[48]  Wei-Tien Chang,et al.  Hawthorn: potential roles in cardiovascular disease. , 2005, The American journal of Chinese medicine.

[49]  Jun-Jie Yin,et al.  Oral administration of Crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils , 2004, Journal of neurochemistry.

[50]  R. Sallabanks Fruit fate, frugivory, and fruit characteristics: a study of the hawthorn, Crataegus monogyna (Rosaceae) , 1992, Oecologia.

[51]  T. Tseng,et al.  Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. , 2003, Journal of agricultural and food chemistry.

[52]  S. Bolling,et al.  Antioxidant capacity of polyphenolic extracts from leaves of Crataegus laevigata and Crataegus monogyna (Hawthorn) subjected to drought and cold stress. , 2003, Journal of agricultural and food chemistry.

[53]  O. Aruoma,et al.  Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. , 2003, Die Nahrung.

[54]  R. Saller,et al.  A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[55]  B. V. Sweet,et al.  Hawthorn: pharmacology and therapeutic uses. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[56]  Yu Huang,et al.  Characterization of antioxidants present in hawthorn fruits. , 2001, The Journal of nutritional biochemistry.

[57]  G. Zapfe jun Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[58]  M. Tendera,et al.  Survival and Prognosis: Investigation of Crataegus Extract WS 1442 in congestive heart failure (SPICE) — rationale, study design and study protocol , 2000, European journal of heart failure.

[59]  S. Habtemariam Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function , 2000 .

[60]  M. J. Cupp Toxicology and Clinical Pharmacology of Herbal Products , 2000 .

[61]  K. Rogers,et al.  Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[62]  S. Habtemariam Natural inhibitors of tumour necrosis factor-alpha production, secretion and function. , 2000, Planta medica.

[63]  B. Meier,et al.  Quantitative reversed-phase high-performance liquid chromatography of procyanidins in Crataegus leaves and flowers , 1999 .

[64]  S. Habtemariam Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. , 1997, Journal of natural products.

[65]  M. T. Sáenz,et al.  Isolation of three triterpenes and several aliphatic alcohols from Crataegus monogyna Jacq. , 1997 .

[66]  R. Puerta,et al.  The Effects of a Triterpene Fraction Isolated from Crataegus monogyna Jacq. on Different Acute Inflammation Models in Rats and Mice. Leucocyte Migration and Phospholipase A2 Inhibition , 1997, The Journal of pharmacy and pharmacology.

[67]  J. Hölzl,et al.  Myocardial effects of flavonoids from Crataegus species. , 1995, Arzneimittel-Forschung.

[68]  T. Bahorun,et al.  Comparative polyphenolic productions in Crataegus monogyna callus cultures , 1994 .

[69]  M. Ploch,et al.  Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II. , 1994, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[70]  R. Heywood,et al.  Toxicity of Crataegus (Hawthorn) Extract (WS 1442) , 1994 .

[71]  J. Chopin,et al.  Di-C-glycosylflavones from crataegus monogyna , 1981 .

[72]  N. R. Farnworth,et al.  Preliminary study of potential antiarrhythmic effects of Crataegus monogyna. , 1974, Journal of pharmaceutical sciences.